GR-196,429

From WikiMD's WELLNESSPEDIA

Error creating thumbnail: File with dimensions greater than 12.5 MP
GR-196,429


GR-196,429 is a drug that acts as a selective antagonist at the neurotransmitter serotonin 5-HT1B and 5-HT1D receptors. It has been used in scientific research to investigate the role of these receptors in the action of various drugs and in physiological processes.

Pharmacology[edit]

GR-196,429 is a potent and selective antagonist for the 5-HT1B and 5-HT1D receptors, with a high affinity for these receptors and a much lower affinity for other serotonin receptor subtypes. This selectivity makes it a useful tool in research into the function of these receptors.

The 5-HT1B and 5-HT1D receptors are found in various parts of the brain and are involved in a wide range of physiological processes. They are thought to play a role in the regulation of mood, anxiety, aggression, and the response to stress, as well as in the control of food intake, sexual behavior, and the release of various hormones.

Research Uses[edit]

GR-196,429 has been used in a variety of research studies to investigate the role of the 5-HT1B and 5-HT1D receptors in these processes. For example, it has been used to study the effects of these receptors on the action of antidepressant drugs, the response to drugs of abuse, and the regulation of food intake and body weight.

In addition, GR-196,429 has been used to investigate the role of these receptors in various disease states, including depression, anxiety disorders, migraine, and eating disorders.

Chemistry[edit]

GR-196,429 is a synthetic compound with a complex chemical structure. It is typically prepared in the laboratory using standard techniques of organic chemistry.

See Also[edit]

References[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.